FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Organicell Regenerative Medicine, Inc. Stock AnalysisComprehensive stock analysis for Organicell Regenerative Medicine, Inc. (BPSR) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisBPSR
BPSR
Organicell Regenerative Medicine, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
BPSR
Home🔹Stocks🔹Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc.

BPSR•OTC

Organicell Regenerative Medicine, Inc.

BPSR•OTC
Sentiment

Your view on BPSR

Sentiment
Your view
BPSR
Organicell Regenerative Medicine, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
BPSR
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Organicell Regenerative Medicine, Inc.

Industry
Biotechnology
Sector
Healthcare
CEO
Albert Mitrani
Headquarters
4045 Sheridan Avenue, Miami, FL, US
Industry
Biotechnology
Sector
Healthcare
CEO
Albert Mitrani
Headquarters
4045 Sheridan Avenue, Miami, FL, US
Description

Organicell Regenerative Medicine, Inc. processes, distributes, and supplies biologically processed cellular and tissue-based products in the United States. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. has an agreement with Regenerative Care Network to study potential therapeutic benefits of Zofin for patients with heart failure. Organicell Regenerative Medicine, Inc. was founded in 2011 and is headquartered in Miami, Florida.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News